Because of the COVID-19 crisis, many surgeries have been cancelled or delayed for patients who qualified for, or had scheduled a total joint replacement or other orthopedic surgical procedure. Post COVID-19, operating rooms will be occupied by other urgent procedures (cardiac, cancer) and many elective procedures will be backlogged. In other words, you may have to wait many months for an elective orthopedic surgical procedure. I am able to provide patients with another option; a procedure that is supported by strong scientific evidence, minimal risks and complications, can be easily performed in the office, and that is FDA cleared for use in orthopedics. These interventions might, or could be, covered by Medicare or private insurance options. This is a great way to keep you in the care continuum with a solution that may provide benefit to you and help you postpone, perhaps even avoid a joint replacement.
An Option for Joint Anthroplasty
April showers bring May flowers
On another note concerning the Personalized Stem Cell Trial, we have high hopes our office will restart the study enrollments in mid-May. My co-investigators will update each of you already enrolled on the timetable and next steps. They realize that those of you already screened will need eligibility reconfirmation and a clinical pathway re-run. We will want to make sure you still qualify and it is safe to proceed including COVID-19 testing.
PSC also has other news on the COVID-19 front. They filed a second Investigational New Drug (IND) application last Wednesday; and, hope to hear from the FDA this week enabling the treatment of COVID-19 patients with allogeneic adipose stem cells while doing their part in the war. The data from the outcomes will also help with upcoming Personalized Stem Cell studies.
Last of all, PSC is considering filing next week to use Stromal Vascular Fraction, that is stem cells from fat (SVF), to treat individual COVID-19 patients after they leave the hospital focusing on the lung damage and fibrosis. Scientists are learning that patients requiring respirators during hospitalization may be at risk for permanent lung disease. An Adipose derived stem cell intervention for active or prevention of lung disease would work nearly identical to our knee study but patients would receive their SVF via intravenous infusion instead of joint injection.
You may visit my website www.sheinkopmd.com or call (312) 475-1893 to schedule an appointment
More later. The latest press release is here: https://www.einpresswire.com/article/514448157/covid-19-emergency-stem-cell-treatment-collaboration-in-san-diego?r=pavRhtj3xPv5Gge7AI